UK's NICE Recommends AbbVie's Follicular Lymphoma Drug

robot
Abstract generation in progress

The UK’s National Institute for Health and Care Excellence (NICE) has recommended AbbVie’s drug for treating follicular lymphoma. This news was reported by MT Newswires. The article also provides recent updates on AbbVie, including FDA approvals for combination therapies and dividend declarations.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
  • Pin